Drug Profile
Research programme: intravenous felbamate - Perosphere
Alternative Names: PER726Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Perosphere
- Class Antiepileptic drugs; Phenylcarbamates; Propylene glycols; Small molecules
- Mechanism of Action NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Brain injuries
Most Recent Events
- 17 Jan 2019 Perosphere has been acquired by AMAG Pharmaceuticals
- 16 Jul 2016 No recent reports of development identified for preclinical development in Brain injuries in USA (IV)
- 17 Apr 2013 Preclinical trials in Brain injuries in USA (IV)